just before conception is extremely rare; and even during the first few weeks of pregnancy, the maternal-fetal transmission rate is low. 10 The risk of fetal infection rises from 6% at 13 weeks to 72% at 36 weeks. Fetuses acquiring infections between 24 and 30 weeks of gestation have been shown to carry the highest risk of suffering from long-term complications. 11 The aim of prenatal serological screening for toxoplasmosis is to identify and treat maternal infection as soon as possible in order to prevent transmission of the parasite to the fetus. However, despite widespread provision of prenatal toxoplasma screening, the effectiveness of prenatal treatment is uncertain. 12 Various histological and serological techniques, such as the Sabin-Feldman dye test, 13 direct hemagglutination test, 14 enzyme-linked immunosorbent assay (ELISA), 15 and indirect fluorescent antibody tests, 16 are commonly applied to detect Toxoplasma gondii infec-tion. For screening purposes, detection of antibodies against T gondii is generally believed to be the most acceptable test. Different assays have been developed to detect anti-toxoplasma antibodies (immunoglobulin M [IgM], IgG, IgA, and IgE) in the sera of pregnant women with a history of repeated abortions and women suspected of being infected with T gondii. 17 The prolonged presence of specific IgM in the peripheral blood makes it difficult to differentiate acute from chronic infection. 18, 19 Detection of Toxoplasma-specific IgA and IgE antibodies in sera of pregnant women appears to be more sensitive than IgM detection during acute infection, but this is awaiting evaluation in a larger study. 20 Seroprevalence studies are useful means of gathering estimates of a population at risk and the number of infected individuals. Screening for T gondii infection by detection of specific IgG and IgM in the antenatal care unit is routinely practiced at King Khalid University Hospital. This study examines the seroprevalence of T gondii during pregnancy.
PATIENTS AND METHODS
This was a retrospective analysis of laboratory data for T gondii screening in the antenatal care unit at the King Khalid University Hospital in Riyadh. Between September 2009 and August 2010, sera from a total of 2176 pregnant women with mean (SD) age of 25 (7.3) years and mean duration of pregnancy of 18 (7.7) weeks were screened in the Immunology Division. Data were extracted for the presence or absence of anti-T gondii IgG and IgM antibodies. Specific IgG antibodies against T gondii were detected by indirect hemagglutination test (Wampole Laboratories, Princeton, NJ).
The test consists of stabilized sheep erythrocytes sensitized with T gondii antigen, which reacts with the antibodies present in the serum. A titer of 1:64 and above indicates a positive test. Although variation in titer may occur, the assay has never been reported to yield a single false-positive or false-negative reaction. Anti-T gondii IgM antibodies were assessed by ELISA (Vircell SL, Santa Fe, Granada, Spain). The assay is based upon the capture of IgM in the sample, with anti-IgM antibodies adsorbed on the polystyrene surface. When compared with other ELISA kits, this kit has been shown to have a sensitivity of 98% and specificity of 100% with virtually no cross-reactivity.
RESULTS
The mean (SD) age of the pregnant females assessed was 25 (7.3) years, and duration of gestation was 18 (7.7) weeks at the time of screening for T gondii infection. Figure 1 shows the seroprevalence of T gondii in 2176 women screened during pregnancy. Of 2176 sera tested, 1351 (62%) did not show any evidence of exposure to T gondii. The rest of the group, comprising 825 (38%) women, tested positive for anti-T gondii IgG antibodies, and none was found to have anti-T gondii IgM antibodies in the serum. These data reveal that a significantly high number of women in the antenatal care unit at King Khalid University Hospital in Riyadh had been exposed to T gondii.
DISCUSSION
The mortality and morbidity associated with congenital toxoplasmosis have prompted several studies involving serological screening for T gondii infection during pregnancy. [21] [22] [23] [24] [25] This study shows that, although none of the women screened during pregnancy had anti-T gondii IgM, 38% tested positive for anti-T gondii IgG, indicating exposure in the past. Similar findings have already been reported in a study from Turkey, in which none of the women during their pregnancy tested positive for anti-T gondii IgM antibodies. 25 On the contrary, there are studies reporting the presence of anti-T gondii-specific IgM antibodies in sera of pregnant women.
21,24,26
The presence of specific IgM is generally believed to be associated with acute infection. However, this may not be true in toxoplasmosis, as the existence of IgM for several months in the sera may interfere in calculating the time of exposure. 17 Differentiation of acute from chronic infection is now being recommended by performing anti-T gondii IgG avidity tests. 20 The presence of low-avidity-specific IgG is believed to be associated with acute infection, whereas the presence of high-avidity IgG indicates exposure in the distant past. Seroprevalence of T gondii assessed by the presence of specific IgG antibodies in this study (38%) when compared with the seroprevalence rate of 3.7% among pregnant Korean women 27 appears to be alarmingly high. The lower rate of seroprevalence in Korean women, however, seems to be unique, as a number of other studies have reported seroprevalence rates between 20% and 43% among pregnant women in other parts of the world. [22] [23] [24] [25] [26] [27] Based on the IgG avidity test and polymerase chain reaction for detection of toxoplasma infection in pregnant women, a separate study from Kuwait has reported toxoplasma prevalence of 53.1%. 28 These data suggest that T gondii seroprevalence among pregnant women exhibits a trend of regional variation. The higher seroprevalence observed in the present study and the study from Kuwait may suggest a tendency towards a higher T gondii seroprevalence in the Middle East.
Regional variation has been attributed to climate, cultural differences in the amount and type of raw meat consumed, and the increased consumption of meat from animals farmed indoors and frozen meat. 6, [29] [30] [31] A multicenter study has identified eating raw or undercooked lamb, beef, or other meat as the most important single risk factor for acquiring toxoplasma infection, apart from some association with travel outside Europe, United States, and Canada. 32 There is sufficient evidence to believe that-compared with beef and chicken-lamb, goat or other meats are more commonly infected and may contain viable cysts. [33] [34] [35] [36] Undercooked lamb but not beef has been identified as a risk factor in Norway, 37 whereas in northern France beef and lamb have been shown to be potent risk factors. 38 Similarly, contact with soil has also been regarded as an independent risk factor for T gondii seroconversion during pregnancy, while contact with cat litter may also pose a risk in certain situations. 39 Identification of regional lifestyle risk factors for toxoplasmosis is of utmost importance for creating awareness for avoidance of toxoplasmosis in general and specifically during pregnancy.
Many pregnant women lack knowledge of the risk factors involved for the transmission of toxoplasmosis. 39 Counseling of pregnant women about risk factor reduction may reduce the risk of congenital toxoplasmosis. The issue is further complicated by the observation that obstetricians, internists, and family practitioners lack relevant education of the risk factors for toxoplasmosis transmission. 39 Studies focusing on education of pregnant women have proven to be effective in increasing general knowledge about toxoplasmosis and potentially decreasing the incidence of congenital toxoplasmosis. 40, 41 This study describes the seroprevalence of T gondii among pregnant women at a single tertiary care hospital, and the findings may not be applicable to the community on the whole. It is therefore recommended that a multicenter study investigating the seroprevalence of T gondii across Saudi Arabia be conducted to assess the actual prevalence of T gondii among pregnant women. In addition, attempts should be made for identification and avoidance of the local sources of infection.
